Factors influencing HPV vaccine delivery by healthcare professionals at public health posts in Sao Paulo, Brazil

Carregando...
Imagem de Miniatura
Citações na Scopus
5
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY-BLACKWELL
Autores
FIGUEROA-DOWNING, Daniella
BAKER, Misha L.
CHIANG, Ellen Dias De Oliveira
EVANS, Dabney P.
BEDNARCZYK, Robert A.
Citação
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, v.136, n.1, p.33-39, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective: To assess the association between Brazilian healthcare providers' characteristics and their knowledge, perceptions, and practices regarding the HPV vaccine. Methods: An observational cross-sectional study was conducted at five public health posts in Sao Paulo between July 28 and August 8, 2014. Healthcare professionals directly involved in patient care were asked to complete a written survey. Factors associated with routine verification of HPV vaccination status were evaluated using Poisson regression. Results: Among 200 participants included, 74 (38.5%) reported never and 70 (36.5%) reported always asking about HPV immunization status. Doctors were significantly less likely to report always asking than were community health agents (5/39 [12.8%] vs 32/60 [53.3%]; adjusted prevalence ratio [aPR] 0.25 [95% confidence interval (CI) 0.07-0.91]). Knowledge about the correct dosing schedule was associated with-always rather than never verifying vaccination status (aPR 2.46 [95% CI 1.06-5.70]). Conclusion: Knowledge and attitude played secondary roles in influencing HPV vaccine verification. Community health agents were crucial for vaccine promotion; continued education and support of this group is essential for the sustained success of HPV immunization efforts in Brazil.
Palavras-chave
Brazil, Cervical cancer, Community health agents, HPV, National immunization program, Vaccine
Referências
  1. Bednarczyk RA, 2013, INT J GYNECOL OBSTET, V121, P224, DOI 10.1016/j.ijgo.2013.01.016
  2. Brazilian Ministry of Health Department of Infectious Disease Surveillance, TECHN BRIEF HUM PAP
  3. Brazilian Ministry of Health, INF SYST NAT IMM PRO
  4. Bruni L, HUMAN PAPILLOMAVIRUS
  5. Chiang EDO, 2015, J HUM GROWTH DEV, V25, P341
  6. Coutinho SB, 2014, PUBLIC HEALTH NUTR, V17, P948, DOI 10.1017/S1368980013001833
  7. Cufino Svitone E, 2000, Rev Panam Salud Publica, V7, P293
  8. DiClemente RJ, 2009, EMERGING THEORIES HL
  9. Fishman J, 2014, PEDIATRICS, V134, pE1049, DOI 10.1542/peds.2013-3454
  10. ICO Information Centre on HPV and Cancer, BRAZ HUM PAP VIR REL
  11. Johnson CD, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-25
  12. Macinko J, 2010, HEALTH AFFAIR, V29, P2149, DOI 10.1377/hlthaff.2010.0251
  13. National Institute of Cancer, ONL ATL MORT
  14. Perlman S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090912
  15. Soares ECC, 2013, INT J TUBERC LUNG D, V17, P1581, DOI 10.5588/ijtld.13.0152
  16. Stormo AR, 2014, ONCOLOGIST, V19, P375, DOI 10.1634/theoncologist.2013-0318
  17. Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F